1. European Pharmacopeia. Section 2.9.18—Preparations for Inhalation: Aerodynamic Assessment of Fine Particles, 5th ed., Council of Europe, Strasbourg, 2005, pp. 2799–2811.
2. United States Pharmacopeia. USP 30-NF 25. Chapter 601—Physical Tests and Determinations: Aerosols, United States Pharmacopeia, Rockville, 2007, pp. 220–240.
3. V. A. Marple, D. L. Roberts, F. J. Romay, N. C. Miller, K. G. Truman, M. Van Oort, B. Olsson, M. J. Holroyd, J. P. Mitchell, and D. Hochrainer. Next generation pharmaceutical impactor. Part 1: design. J. Aerosol Med.
16:283–299 (2003).
4. J. Heyder, and M. U. Svartengren. Basic principles of particle behavior in the human respiratory tract. In H. Bisgaard, C. O’Callaghan, and G.C. Smaldone (eds.), Drug delivery to the lung, Marcel Dekker, New York, 2002, pp. 21–45.
5. G. Rudolph, R. Kobrich, and W. Stahlhofen. Modeling and algebraic formulation of regional aerosol deposition in man. J. Aerosol Sci.
21(S1):S403–S406 (1990).